amyotrophic lateral sclerosis, 22 and multiple sclerosis. 23 CCM also has prognostic ability as it can predict the development of diabetic neuropathy. 24 Both dysglycemia and dyslipidemia are associated with corneal nerve loss 18 and improvement in blood pressure, lipids, HbA1c, 25 and glucose tolerance, 26 all risk factors for stroke, result in an improvement in corneal nerve morphology. In addition, intraepidermal nerve fiber loss has been found in patients with stroke, 27 particularly in those with central poststroke pain.
A cute ischemic stroke is the leading cause of acquired disability and the second most common cause of death. 1 The major risk factors for stroke include diabetes mellitus, hypertension, smoking, dyslipidemia, [2] [3] [4] [5] [6] [7] [8] and metabolic syndrome. 9 A recent analysis of hospitalization data from the National Inpatient Sample has shown a doubling of admissions and risk factors for ischemic stroke among young adults in the United States. 10 Patients admitted with acute stroke in Qatar are significantly younger than patients presenting with stroke in Europe and the United States, and they do not necessarily have the traditional risk factors for stroke. [11] [12] [13] It is therefore important to develop new methods, which can identify people who may be at increased risk of stroke.
Magnetic resonance imaging can identify silent infarcts, cerebral microbleeds, periventricular white matter hyperintensities, and perivascular spaces, and they have been shown to predict a higher risk of stroke. 14, 15 Subtle alterations in the microstructure of normal-appearing white matter, independent of prevalent vascular lesions, also predict the risk of stroke. 16 We think that there is an unmet need for noninvasive imaging methods to identify subclinical neuronal damage and hence people at higher risk of stroke.
Corneal confocal microscopy (CCM) is a rapid noninvasive ophthalmic imaging technique, which allows high-resolution imaging of corneal nerves at ×600 magnification. We have pioneered its use to identify axonal loss in diabetic 17, 18 and other 19, 20 peripheral neuropathies. Furthermore, we and others have also demonstrated corneal nerve loss in central neurodegenerative conditions such as Parkinson's disease,
In the present study, we have undertaken CCM and quantified corneal nerve fiber pathology in relation to risk factors for stroke in a cohort of patients with normal glucose tolerance (NGT) and impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM), admitted with acute ischemic stroke.
Methods
One hundred thirty patients underwent CCM within the first week of admission with acute ischemic stroke. Stroke was confirmed clinically and radiologically by a stroke neurologist and neuroradiologist based on the 2013 AHA/ASA definition. 29 Patients with intracerebral hemorrhage, a known history of ocular trauma or surgery and any corneal or anterior segment pathology and history of severe dry eye disease, were excluded.
This study adhered to the tenets of the declaration of Helsinki and was approved by the Institutional Review Board of Hamad General Hospital (15304/15). Informed, written consent was obtained from all patients/guardians before participation in the study.
Clinical demographic parameters, blood pressure, HbA1c, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides were assessed on admission. Stroke patients were classified into 3 groups: NGT (HbA1c, <5.7%); IGT (HbA1c, 5.7-6.4%), and T2DM (HbA1c, ≥6.5%).
Corneal Confocal Microscopy
All patients underwent CCM (Heidelberg Retinal Tomograph III Rostock Cornea Module; Heidelberg Engineering GmbH, Heidelberg, Germany). This device uses a 670 nm wavelength helium neon diode laser, which is a class I laser and therefore does not pose any ocular safety hazard. A ×63 objective lens with a numeric aperture of 0.9 and a working distance, relative to the applanating cap (TomoCap; Heidelberg Engineering GmbH) of 0.0 to 3.0 mm, is used. The size of each 2-dimensional image produced is 384×384 μm with a 15°×15° field of view and 10 μm/pixel transverse optical resolution. To perform the CCM examination, local anesthetic (0.4% benoxinate hydrochloride; Chauvin Pharmaceuticals, Chefaro, United Kingdom) was used to anesthetize each eye, and Viscotears (Carbomer 980, 0.2%, Novartis, United Kingdom) were used as the coupling agent between the cornea and the applanating cap. All patients were asked to fixate on an outer fixation light throughout the CCM scan, and a CCD camera was used to correctly position the applanating cap onto the cornea. 30 The examination took ≈10 minutes for both eyes, and experienced examiners (A.K., G.P., and I.N.P.), masked from the subject's clinical status, captured central sub-basal nerve plexus images using the section mode.
On the basis of depth, contrast, focus, and position, 6 images per subject were selected and analyzed. 31 All CCM images were analyzed using validated, purpose-written software (CCMetrics; M. A. Dabbah, ISBE, University of Manchester, Manchester, United Kingdom). 17 Corneal nerve fiber density (CNFD), corneal nerve branch density, and corneal nerve fiber length were quantified ( Figure 1 ).
Statistical Analysis
All statistical analysis was performed using IBM SPSS Statistics software Version 24. Normality of the distribution of data was examined using the Kolmogorov-Smirnov test and by visual inspection of the histogram and a normal Q-Q plot. Data are expressed as the mean±SD (Table 1) . Each group was compared using ANOVA (for normally distributed variables) with Bonferroni as post hoc test and the nonparametric Kruskal-Wallis test (for non-normally distributed variables). To investigate the association between risk factors for stroke and corneal nerve parameters, Pearson correlation was performed to look for the factors, which contribute to nerve damage. Multiple linear regressions were conducted to assess independent association between corneal nerve metrics and the covariates. Significance level Figure 1 . Representative images of the sub-basal nerve plexus of a healthy control participant (A), a stroke patient with normal glucose tolerance (B), a stroke patient with impaired glucose tolerance (C) and a stroke patient with type 2 diabetes mellitus (D).
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Results

Clinical and Metabolic Characteristics
The clinical and laboratory characteristics of the participants are given in 
Corneal Confocal Microscopy
There was a significant reduction in CNFD, corneal nerve branch density, and corneal nerve fiber length in stroke 
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patients compared with healthy controls ( Figures 3 and 4) .
Multiple Linear Regression
There were no independent associations between corneal nerve measures and age, body mass index, HbA1c, triglycerides, total cholesterol, LDL, HDL, systolic, and diastolic blood pressures (Table 2) .
Discussion
This is the first study to demonstrate a loss of corneal nerve fibers in patients presenting with acute ischemic stroke, irrespective of glycemic status. We also show modest correlations between corneal nerve parameters and HbA1c and triglycerides. Previously, alterations in the microstructure of normalappearing white matter 16 on diffusion tensor magnetic resonance imaging have been associated with body mass index, 32, 33 HbA1c, 34 cholesterol, 35 hypertension, 36 and insulin resistance, 37 suggesting an association of these risk factors with white matter lesions. In turn, the presence of white matter lesions, subclinical small vessel disease, and alterations in the white matter microstructure increase the risk of stroke. 16 However, it is neither feasible nor practical because of accessibility, cost, and logistics to undertake magnetic resonance imaging to identify those at risk of stroke.
We have pioneered CCM as a noninvasive ophthalmic imaging technique to detect corneal nerve damage in patients with diabetic neuropathy. 18, 26 Furthermore, the severity of corneal nerve damage has been associated with HDL, 38 and we have previously shown an improvement in CNFD with an improvement in systolic blood pressure, LDL, and HbA1c. 25 Patients with hyperglycemia 39 and hypertension 40, 41 have worse neurological and functional outcomes after acute ischemic stroke, which may be because of poorer neuronal reserve, before a stroke. The demonstration of peripheral nerve damage in a condition where the primary focus is damage to the central cerebral neurons is challenging. However, a recent study has shown a loss of intraepidermal nerve fibers in stroke patients, 27 although it did not assess the association with diabetes mellitus or other vascular risk factors. Intraepidermal nerve fiber loss has also been shown in patients with central poststroke pain. 28 These studies suggest that there may be peripheral nerve damage in people before a stroke. However, skin biopsy is invasive, and the quantification of intraepidermal nerve fibers requires considerable expertise. In comparison to skin biopsy, CCM is a rapid noninvasive ophthalmic imaging technique used in ophthalmic practice to study the cornea. It requires minimal expertise to capture corneal nerve images, and available automated software can easily quantify corneal nerve damage. 17, 42 Although we first demonstrated corneal nerve loss in patients with diabetes mellitus, we have subsequently shown corneal nerve loss in subjects with idiopathic small fiber neuropathy and a range of other neuropathies in people with NGT. High triglycerides and lower HDL contribute to the development of diabetic neuropathy, 43 and indeed lower HDL is associated with corneal nerve loss in patients with diabetes mellitus. 38 In addition, we and others have also shown corneal nerve loss in patients with Parkinson's disease 21 and multiple sclerosis, 23 with NGT. 44, 45 In the present study, we now demonstrate significant corneal nerve loss in patients with acute ischemic stroke and NGT, with slight but nonsignificant worsening in those with IGT and T2DM, indicating that hyperglycemia is not necessarily the main driver for corneal nerve loss in patients with stroke. Although we show modest correlations between corneal nerve loss and elevated triglycerides and HbA1c, multiple linear regression shows no association between the reduction in corneal nerve parameters and traditional risk factors for stroke, including age, glycemic control, lipids, and blood pressure. This indicates that corneal nerve loss in patients with stroke can only be partially explained by risk factors for peripheral nerve damage.
The limitation of this study is its relatively small size and the inclusion of patients with only mild-to-moderate stroke, based on the National Institutes of Heath Stroke Scale score. However, CCM identified corneal nerve fiber abnormalities in patients with acute ischemic stroke, with and without dysglycemia, and it may reflect the cumulative consequence of known and unknown risk factors for neuronal loss in stroke. Our study broadens the clinical use of CCM in the assessment of patients with peripheral and central neurodegenerative disorders. Larger, longitudinal follow-up studies are required to determine the prognostic ability of CCM as a surrogate imaging biomarker of neuronal damage in patients with acute ischemic stroke.
